Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA230346
Max Phase: Preclinical
Molecular Formula: C24H28O2
Molecular Weight: 348.49
Molecule Type: Small molecule
Associated Items:
ID: ALA230346
Max Phase: Preclinical
Molecular Formula: C24H28O2
Molecular Weight: 348.49
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: C=CCc1cc(/C(CC)=C(\CC)c2ccc(O)c(CC=C)c2)ccc1O
Standard InChI: InChI=1S/C24H28O2/c1-5-9-19-15-17(11-13-23(19)25)21(7-3)22(8-4)18-12-14-24(26)20(16-18)10-6-2/h5-6,11-16,25-26H,1-2,7-10H2,3-4H3/b22-21+
Standard InChI Key: NUKHDOPGAIWQMC-QURGRASLSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 348.49 | Molecular Weight (Monoisotopic): 348.2089 | AlogP: 6.29 | #Rotatable Bonds: 8 |
Polar Surface Area: 40.46 | Molecular Species: NEUTRAL | HBA: 2 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 8.43 | CX Basic pKa: | CX LogP: 7.39 | CX LogD: 7.35 |
Aromatic Rings: 2 | Heavy Atoms: 26 | QED Weighted: 0.43 | Np Likeness Score: 0.45 |
1. Amblard F, Govindarajan B, Lefkove B, Rapp KL, Detorio M, Arbiser JL, Schinazi RF.. (2007) Synthesis, cytotoxicity, and antiviral activities of new neolignans related to honokiol and magnolol., 17 (16): [PMID:17587572] [10.1016/j.bmcl.2007.06.024] |
2. Lin D, Yan Z, Chen A, Ye J, Hu A, Liu J, Peng J, Wu X.. (2019) Anti-proliferative activity and structure-activity relationship of honokiol derivatives., 27 (16): [PMID:31278004] [10.1016/j.bmc.2019.06.042] |
Source(1):